OSI Closes Lid On Eyetech Acquisition
Despite last-minute blink surrounding potential Macugen competition from Genentech’s Lucentis, OSI announces completion of the $935 mil. merger.
Despite last-minute blink surrounding potential Macugen competition from Genentech’s Lucentis, OSI announces completion of the $935 mil. merger.